Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13,831,528
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
683,341
-
Shares change
-
-21,109
-
Total reported value, excl. options
-
$1,173,672
-
Value change
-
-$35,542
-
Number of buys
-
5
-
Number of sells
-
5
-
Price
-
$1.72
Institutional Holders of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) as of Q4 2023
As of 31 Dec 2023 Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) had 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 683,341 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, SUSQUEHANNA INTERNATIONAL GROUP, LLP, STATE STREET CORP, NORTHERN TRUST CORP, BANK OF AMERICA CORP /DE/, and Tower Research Capital LLC (TRC).
This table shows 16 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.